The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality

The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality During the Initial Healing Phase

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04412135

Acronym

SPIRIHEMATO

Enrollment

Registered

2020-06-02

Start date

2020-06-01

Completion date

2021-06-01

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic Cancer

Brief summary

The management of patients with malignant hemopathy is based on comprehensive management. In this context and faced with the various difficulties encountered by cancer patients, the question of spirituality and its experience is central. Spirituality refers to the person's attachment to what inspires and gives him foundation, as well as the beliefs, values, and existential experiences associated with it, whether these are religious in nature or not. Although the concept has been identified as a resource in the literature and widely treated in an end-of-life context, assessing the needs of patients with hematological cancer and their loved ones in terms of spirituality from the initiation of treatment does not has not been developed

Interventions

OTHERspirituality

Patients will take three questionnaires (FACIT-Sp, Euroqol 5 dimensions and ESAS)

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Aged ≥ 18 years with a recent diagnosis of hematological cancer (lymphoma or leukemia) and in treatment; * Patients who speak and read French; * Patients in general condition (physical and mental) judged emotionally and physically fit by the referring nurse to answer the questionnaires; * Patients benefiting from a social security scheme, * Patients who signed the non-objection form after being informed of the study, family person: * Have been designated by the patient as being the loved one they wish to include with them; * Aged ≥ 18 years; * Fluent in and reading French; * Having signed the non-objection form after being informed of the study.

Exclusion criteria

* Patients in recurrence / progress or in remission of cancer; * Patients in the terminal phase of the disease. Family person: person in the curative phase of cancer

Design outcomes

Primary

Measure	Time frame
FACIT-Sp questionnaire	15 minutes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026